10-Q: Kindly MD Reports Q1 2025 Results: Revenue Declines Amid Shift to Insurance Billing, Net Loss Widens

Kindly MD's Q1 2025 revenue decreased by 30.1% year-over-year, and the net loss increased significantly as the company transitions to insurance-based billing and invests in operational expansion.

Summary

• Kindly MD reported a net revenue of $579,655 for the three months ended March 31, 2025, a 30.1% decrease compared to $829,029 for the same period in 2024.
• The decrease in revenue is primarily due to a decline in cash-pay patient care services as the company shifts towards insurance billing.
• Operating expenses increased by 52.1% to $1,621,396, driven by higher salaries, wages, and general and administrative costs.
• The company's net loss for the quarter was $1,038,011, significantly higher than the $282,326 loss in Q1 2024.
• Net loss per share increased to $(0.17) compared to $(0.06) in the prior year.
• Cash and cash equivalents stood at $1,140,574 as of March 31, 2025, with a working capital of $732,210.
• The company used $865,083 in operating activities during the quarter.
• Management acknowledges the decrease in working capital and is focused on increasing cash reserves and liquidity in the near term through strategic transactions.
• The company is working to remediate material weaknesses in internal control over financial reporting.

Sentiment

Score: 4

Explanation: The report presents a mixed picture. While there are positives such as increased insurance reimbursements and efforts to improve internal controls, the significant revenue decline, widening net loss, and decreased cash position raise concerns. The sentiment is cautiously negative.

Positives

• Reimbursements from insurance payers increased by 145.6% to $85,273, indicating progress in the shift towards insurance billing.
• Interest expense decreased by 88.9% due to a reduction of notes payable and amortization of debt discounts.
• The company completed an IPO in June 2024, providing liquidity and cash reserves.
• The company is actively working to remediate material weaknesses in its internal control over financial reporting.

Negatives

• Net revenues decreased by 30.1% to $579,655, primarily due to a decrease in cash-pay patient care services.
• Operating expenses increased by 52.1% to $1,621,396, driven by increases in salaries and wages and general and administrative expenses.
• The net loss widened to $1,038,011, compared to $282,326 in the same period last year.
• The company's cash and cash equivalents decreased to $1,140,574 as of March 31, 2025.
• Management acknowledges the decrease in working capital and is focused on increasing cash reserves and liquidity in the near term through strategic transactions.
• The company identified material weaknesses in its internal control over financial reporting.

Risks

• The company's ability to raise capital is necessary to sustain anticipated operations and implement its business plan.
• The company's ability to generate sufficient cash to survive is uncertain.
• The company faces competition in the healthcare market.
• The company's business plan lacks diversification.
• The company is exposed to the general volatility of the capital markets.
• The company identified material weaknesses in its internal control over financial reporting.

Future Outlook

Management acknowledges the decrease in working capital and is focused on increasing cash reserves and liquidity in the near term through strategic transactions. Kindly MD management strives to look for opportunities to optimize revenue by increasing sales, improving margins, and controlling ongoing operating expenses.

Management Comments

• Kindly MD believes these methods to be superior in managing the root cause of symptoms and improving health outcomes faster.
• Kindly MD is most successful when patients report positive health outcomes and high satisfaction as a result of our care.
• Management acknowledges the decrease in working capital and is focused on increasing cash reserves and liquidity in the near term through strategic transactions.

Industry Context

The company operates in the healthcare industry, specifically focusing on value-based care and alternative medicine. The shift towards insurance billing reflects a broader trend in the healthcare industry to increase accessibility and affordability of medical services. The company's focus on reducing opioid use aligns with national efforts to combat the opioid epidemic.

Comparison to Industry Standards

• It is difficult to compare Kindly MD directly to industry standards without knowing the specific segments it competes in and the size of comparable companies.
• However, the shift to insurance billing is a common strategy among healthcare providers to increase patient volume and revenue stability, similar to practices adopted by larger healthcare organizations like UnitedHealth Group or CVS Health.
• The focus on alternative medicine and mental health integration is a differentiating factor, potentially aligning with smaller, specialized clinics and telehealth providers.
• The reported net loss and cash flow challenges are not uncommon for emerging growth companies in the healthcare sector, especially those investing in technology and expansion, similar to companies like Teladoc Health in their early stages.

Legal Proceedings

• From time to time, the Company may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business.
• However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business.
• We know of no existing or pending legal proceedings against us, nor are we involved as a plaintiff in any proceeding or pending litigation.
• There are no proceedings in which any of our directors, officers or any of their respective affiliates, or any beneficial stockholder, is an adverse party or has a material interest adverse to our interest.

Stakeholder Impact

• Shareholders may be concerned about the decreased revenue, increased net loss, and decreased cash position.
• Employees may be affected by potential cost-cutting measures to improve financial performance.
• Customers may experience changes in service offerings as the company shifts towards insurance billing.
• Suppliers and creditors may be impacted by the company's efforts to manage cash flow.

Next Steps

• Management plans to increase cash reserves and liquidity through strategic transactions.
• The company will continue to implement its strategic operational business plans to create sustained cash flow generation.
• The company will continue to enhance corporate oversight over process-level controls and structures to ensure that there is appropriate assignment of authority, responsibility, and accountability to enable remediation of our material weaknesses.

Key Dates

Keywords

financial results, quarterly report, Kindly MD, healthcare, revenue, net loss, operating expenses, insurance billing, internal control, cash flow